Literature DB >> 19065350

Immunopathology of hepatitis B virus infection.

Hsiu-Ting Tsai1, Tzu-Hsin Tsai, Tsong-Ming Lu, Chi-Chiang Yang.   

Abstract

The interaction between immune responses and hepatitis B virus (HBV) is coordinated between innate and adaptive immunity. Anti-HBs antibodies protect the host by blocking the binding ability of HBV. Anti-HBc antibodies are detected with persistent HBV infection. The presence of anti-HBe antibodies is often associated with recovery from active diseases and is clinically used as a benchmark to assess response to treatment. Our studies have revealed that the anti-HBV immunoglobulins secreted are different in subclass patterns in different HBV infection status populations. These revelations may help to understand HBV escape and persistent infection and to develop strategies for prevention and therapeutic management of HBV infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19065350     DOI: 10.1080/08830180802295757

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  5 in total

1.  Screening and bioinformatic analysis of microRNA-associated immune clearance in patients with chronic hepatitis B.

Authors:  Tong-Jing Xing; Bian Wang; Jing Zhang
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Expression profile and clinical significance of miRNAs at different stages of chronic hepatitis B virus infection.

Authors:  Tongjing Xing; Hongtao Xu; Wenqing Yu; Bian Wang; Jing Zhang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

3.  The association between preoperative serum C-reactive protein and hepatocellular carcinoma recurrence in patients with chronic hepatitis B virus (HBV) infection--a retrospective study.

Authors:  Xiaoming Zhao; Jingyu Luo; Bobo Li; Shuguang Liu; Daotang Li
Journal:  PLoS One       Date:  2015-01-20       Impact factor: 3.240

4.  Clinical and Virological Characteristics of Chronic Hepatitis B Patients with Coexistence of HBsAg and Anti-HBs.

Authors:  Yong Liu; Le Zhang; Jin-Yong Zhou; Jinshun Pan; Wei Hu; Yi-Hua Zhou
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

5.  MiRNA-548ah, a potential molecule associated with transition from immune tolerance to immune activation of chronic hepatitis B.

Authors:  Tong-Jing Xing; Hong-Tao Xu; Wen-Qing Yu; Bian Wang; Jing Zhang
Journal:  Int J Mol Sci       Date:  2014-08-19       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.